AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

Background
This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program. ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health care coverage assistance).
HRSA will base ADAP ERF awards upon your ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists.

Grant Details
The purpose of this program is to provide funding to states/territories to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures. The funds are to be used in conjunction with the Ryan White HIV/AIDS Program (RWHAP) Part B ADAP administered by the HRSA, HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP).
The estimated total available funding is approximately $75,000,000 annually to fund 25 recipients. The actual amount available will not be determined until enactment of the final FY 2024 federal appropriation.
If a state/territory has a current ADAP waiting list, they may apply for a ceiling amount of up to $10,000,000 total cost. If they do not have a current ADAP waiting list, they may apply for a ceiling amount of up to $7,000,000 total cost.
The period of performance is April 1, 2024 through March 31, 2025.

Eligibility Requirements
Eligible applicants are limited to RWHAP Part B states/territories that need additional funding to reduce or eliminate an existing ADAP waiting list, actively prevent the implementation of an ADAP waiting list, address a projected increase in treatment needs aligned with ending the HIV epidemic in the U.S., and/or address other unanticipated increases in the number of clients in the program due to new diagnosis, re-engagement in care, loss of income, and/or loss of health care coverage.
States/territories that do not currently meet one or more of these criteria are not eligible to apply. Tribes and tribal organizations are not eligible for this funding.

Period of Performance
April 1, 2024 through March 31, 2025

Grant Value
$75,000,000 annually with individual grant awards up to $10,000,000 for applicants with a current ADAP waiting list and up to $7,000,000 for applicants without a current ADAP waiting list

Place of Performance
All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands,
Guam,
American Samoa,
the Commonwealth of the Northern Mariana Islands,
the Republic of Palau,
the Federated States of Micronesia and
the Republic of the Marshall Islands